News
Orion & Criceto signs agreement to develop and commercialise Aporon, an innovative apomorphine spray to treat OFF episodes in Parkinson’s disease: Espoo, Finland Monday, April 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback